Physicianscare Sinus Tablet, Film Coated
NDC Package 0924-0133-01
Package Information
Physicianscare Sinus (phenylephrine hcl) tablets is a medication used for temporary relief of congestion in the nose caused by various conditions including the common cold, sinusitis, hay fever, and allergies. This formulation utilizes a tablet, film coated delivery system. Marketed by Acme United Corporation, this product is identified by NDC 0924-0133 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1049182 - phenylephrine HCl 10 MG Oral Tablet
- RxCUI: 1049182 - phenylephrine hydrochloride 10 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0924 - Acme United Corporation
- 0924-0133 - Physicianscare Sinus
- 0924-0133-01 - 50 PACKET in 1 CARTON / 1 TABLET, FILM COATED in 1 PACKET (0924-0133-00)
- 0924-0133 - Physicianscare Sinus
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0924-0133). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0924-0133-01 identifies a specific commercial package of 50 packet in 1 carton / 1 tablet, film coated in 1 packet (0924-0133-00) of Physicianscare Sinus Non-drowsy, a human over the counter drug labeled by Acme United Corporation. This tablet, film coated is formulated for oral use and contains phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Acme United Corporation on January 29, 2012. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used for temporary relief of congestion in the nose caused by various conditions including the common cold, sinusitis, hay fever, and allergies. It works by narrowing the blood vessels in the nose area, reducing swelling and congestion.
How is this Acme United Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00924013301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.